Thyroid Panel

Navigation & Literature

• Parent Silo: 03 - Diagnostics & Quantified Self MOC
• Literature Dossier: Thyroid Panel - References

---

1. Reference Range Comparison (Standard vs. Longevity Optimal)

Sub-Marker	Standard Clinical Range	Longevity / Functional Optimal	Primary Unit	Physiological Meaning
TSH (Thyroid Stimulating Hormone)	$0.45–4.50\text{ mIU/L}$	$0.8–2.0\text{ mIU/L}$	$\text{mIU/L}$	Pituitary thyrotroph feedback signal; log-linear sensitivity to central T4/T3
Free T3 (Triiodothyronine)	$2.0–4.4\text{ pg/mL}$	$3.2–4.2\text{ pg/mL}$ (upper half of range)	$\text{pg/mL}$	Biologically active thyroid hormone binding nuclear TR$\alpha$/TR$\beta$ receptors
Free T4 (Thyroxine)	$0.82–1.77\text{ ng/dL}$	$1.1–1.5\text{ ng/dL}$	$\text{ng/dL}$	Prohormone reservoir secreted by thyroid gland (80–90% of glandular output)
Reverse T3 (rT3)	$9.2–24.1\text{ ng/dL}$	$<15.0\text{ ng/dL}$ ($\text{Free T3 : rT3 ratio}>20$)	$\text{ng/dL}$	Metabolically inactive isomer formed via Type 3 deiodinase (D3) during stress/illness
TPO Antibodies (TPOAb)	$<34\text{ IU/mL}$ (or $<9\text{ IU/mL}$)	$<10\text{ IU/mL}$ (Undetectable)	$\text{IU/mL}$	Autoimmune cytotoxicity against thyroid peroxidase (Hashimoto’s thyroiditis)
Thyroglobulin Antibodies (TgAb)	$<4.0\text{ IU/mL}$ (or $<1\text{ IU/mL}$)	$<1.0\text{ IU/mL}$ (Undetectable)	$\text{IU/mL}$	Autoimmune reactivity against thyroglobulin colloid storage protein

Assay Interference Alert (Biotin)

High-dose Biotin (Vitamin B7 $>5\text{ mg/day}$) interferes with streptavidin-biotin immunoassays, causing falsely low TSH and falsely elevated Free T4/Free T3 (mimicking Graves’ hyperthyroidism). Always discontinue biotin for 72 hours prior to venipuncture.

---

2. Physiological Significance & Hazard Curves

Deiodinase Enzymology & Peripheral T4 $\to$ T3 Conversion

The thyroid gland secretes predominantly prohormone T4 (~85%) and only ~15% active T3. Intracellular metabolic rate, mitochondrial uncoupling (UCPs), hepatic LDL receptor expression, and cardiac contractility depend on tissue-specific selenocysteine deiodinase enzymes:

• Type 1 (D1, liver/kidney): Converts T4 $\to$ T3 for systemic circulation; downregulated by pro-inflammatory cytokines (IL-6, TNF-$\alpha$), caloric restriction, and selenium deficiency.
• Type 2 (D2, brain/pituitary/brown adipose/skeletal muscle): Locally converts T4 $\to$ T3; pituitary D2 is highly efficient, meaning TSH can remain normal ($1.5\text{ mIU/L}$) even when peripheral D1 conversion is impaired and peripheral Free T3 is suboptimal.
• Type 3 (D3, ubiquitous under stress): Converts T4 into inactive Reverse T3 (rT3) and degrades T3 into T2. Under high cortisol, severe caloric restriction, chronic inflammation, or iron deficiency, D3 upregulates (“non-thyroidal illness” or cellular hypothyroidism), elevating rT3 ($>18\text{ ng/dL}$) and lowering basal metabolic rate and core body temperature.

Subclinical Hypothyroidism, Dyslipidemia & Cardiovascular Risk

Thyroid hormone acts on hepatic TR$\beta$ receptors to upregulate LDL receptor (LDLR) transcription and cholesterol $7\alpha$-hydroxylase (bile acid synthesis). Consequently, a sluggish thyroid axis ($\text{TSH}>2.5–3.0\text{ mIU/L}$ or $\text{Free T3}<2.8\text{ pg/mL}$) is one of the most common reversible secondary causes of elevated ApoB and LDL-C (see Cardiometabolic Panel (ApoB, Lp(a), HbA1c, Fasting Insulin)). Conversely, in octogenarians and centenarians (Leiden Longevity Study), slightly higher TSH ($2.5–4.5\text{ mIU/L}$) is heritably associated with lower basal metabolic ROS and extreme longevity, illustrating an age-dependent shift between young/middle-aged performance optimization ($\text{TSH }0.8–2.0\text{ mIU/L}$) and late-life hypometabolic preservation.

Low T3 Syndrome & Mortality

In prospective cardiovascular and intensive care cohorts, Low Free T3 ($<2.3–2.6\text{ pg/mL}$) is the single strongest thyroid predictor of all-cause and cardiac mortality ($\text{HR }1.8–2.6$), outperforming TSH and Free T4 because Free T3 directly integrates systemic energetic capacity, selenium/iron status, and inflammatory burden.

---

3. Root Causes of Dysregulation

• Suboptimal Free T3 / Elevated rT3 (Poor T4 $\to$ T3 Conversion): Selenium or zinc deficiency (D1/D2 cofactors), low ferritin ($<40\text{ ng/mL}$ impairs heme-dependent thyroid peroxidase; see Hematology, Iron & Nutrient Panel), chronic caloric deficit or zero-carbohydrate ketogenic diets (insulin is permissive for hepatic D1 activity), elevated cortisol (HPA Axis & Cortisol Modulation), and systemic inflammation (Inflammation & Oxidative Stress (hs-CRP, Homocysteine, GGT)).
• Elevated TPOAb / TgAb (Autoimmune Thyroiditis): Intestinal hyperpermeability and molecular mimicry (gluten gliadin cross-reactivity with thyroid tissue; see Intestinal Permeability & Zonulin), excess iodine supplementation without adequate selenium (oxidative H2O2 damage during iodination), and Vitamin D deficiency.

---

4. Actionable Interventions

Foundational Protocols (01 - Foundations)

• Strategic Carbohydrate Refeeding & Metabolic Flexibility: Avoid prolonged aggressive caloric deficits; periodic carbohydrate refeeds restore leptin and insulin signaling required for hepatic D1 conversion of T4 $\to$ T3 per Metabolic Flexibility & Insulin Sensitivity and Macronutrient & Micronutrient Optimization.
• HPA Axis De-escalation: Lower elevated evening cortisol (which inhibits D1 and upregulates D3 $\to$ rT3) via HPA Axis & Cortisol Modulation and Sleep Architecture.

Molecular & Pharmacological Interventions (02 - Compounds & Molecules)

• Deiodinase & Peroxidase Cofactors:
  • Selenomethionine ($100–200\mu \text{g/day}$): Essential for selenoprotein deiodinases (D1/D2) and glutathione peroxidase (GPx3) protection of thyroid follicles; clinically proven to reduce TPOAb titers by 20–40%.
  • Iron / Ferritin Restoration: Target ferritin $60–100\text{ ng/mL}$ for optimal heme-dependent TPO activity (Hematology, Iron & Nutrient Panel).
  • Myo-Inositol ($600–2000\text{ mg/day}$) + Selenium: Enhances TSH receptor (TSHR) phosphatidylinositol second-messenger signaling, normalizing subclinical TSH elevations.
  • L-Tyrosine ($500–1000\text{ mg}$): Amino acid backbone of thyroglobulin iodination (Dopaminergics & Catecholamines).
  • Ashwagandha ($300–600\text{ mg}$): Stimulates T4/T3 synthesis in subclinical hypothyroidism via Adaptogens (caution in hyperthyroidism).

---

5. Key Scientific Evidence Summary

• Rodondi et al. (2010, JAMA): Thyroid Studies Collaboration IPD meta-analysis ($n=55,287$) quantifying coronary heart disease events and mortality across TSH thresholds.
• Iervasi et al. (2003, Circulation): Demonstrated in 573 cardiac patients that low Free T3 is the most powerful independent predictor of cumulative cardiovascular and all-cause death ($\text{HR }3.6$).
• Wichman et al. (2016, Thyroid): Systematic review and meta-analysis of 16 controlled trials confirming selenium supplementation significantly reduces serum TPOAb and TgAb levels in chronic autoimmune thyroiditis.

See full bibliographic details and quantitative effect sizes in Thyroid Panel - References.